The difference was only partially explained by more-advanced disease at the time of ART initiation and differential loss to follow-up.
Previous studies of HIV-infected individuals receiving antiretroviral therapy (ART) in sub-Saharan Africa have shown higher mortality among men than women. Now, researchers have evaluated the magnitude and predictors of this difference among 46,201 treatment-naive adults (65% female) who started ART in South Africa between 2002 and 2009. Total follow-up time was nearly 78,000 person-years.
At ART initiation, men were older than women (38 vs. 33), had lower median CD4 counts (85 vs. 110 cells/mm3) and were more likely to have advanced HIV disease (86% vs. 77%). During 36 months of follow-up, mortality was significantly higher among men than women (hazard ratio, 1.5), and this difference persisted even after adjustment for age, baseline CD4-ce…
Reviewing Author
DisclosuresConsultant/Advisory BoardUNAIDS; WHO; Bill and Melinda Gates Foundation, Population Council
Grant/Research SupportNIH; National Institute of Allergy and Infectious Diseases; Tides Foundation/MAC AIDS Fund; USAID; South African National Research Foundation; European Union; South African Medical Research Council
Editorial BoardsNew England Journal of Medicine; AIDS Reviews; AIDS Research and Human Retroviruses; mBio; Indian Journal of Medical Research; JAIDS: Journal of Acquired Immune Deficiency Syndromes
DisclosuresConsultant/Advisory BoardUNAIDS; WHO; Bill and Melinda Gates Foundation, Population Council
Grant/Research SupportNIH; National Institute of Allergy and Infectious Diseases; Tides Foundation/MAC AIDS Fund; USAID; South African National Research Foundation; European Union; South African Medical Research Council
Editorial BoardsNew England Journal of Medicine; AIDS Reviews; AIDS Research and Human Retroviruses; mBio; Indian Journal of Medical Research; JAIDS: Journal of Acquired Immune Deficiency Syndromes